Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 114 for “"Single-agents"”.

  1. Design and Synthesis of Pyrimidine Fused Heterocycles as Single Agents with Combination Chemotherapy Potential

    … evaluation of pyrimidine fused heterocycles as single agents with combination chemotherapy potential. Major limitations of cancer chemotherapy include dose limiting toxicities of clinically used agents and the development of multidrug resistance by the tumor. Agents that interfere with …

    duquesne Repository record for Design and Synthesis of Pyrimidine Fused Heterocycles as Single Agents with Combination Chemotherapy Potential (opens in a new tab)

  2. DESIGN AND SYNTHESIS OF FUSED PYRIMIDINES AS SINGLE AGENTS WITH COMBINATION CHEMOTHERAPY POTENTIAL, AS TUBULIN POLYMERIZATION AND ONE-CARBON METABOLISM INHIBITORS FOR CANCER

    … evaluation of bicyclic fused pyrimidines as single agents with combination chemotherapy potential with both antiangiogenic and cytotoxic effects. The dissertation also discusses one-carbon metabolism inhibitors and tumor targeting proteolysis targeting chimeras (PROTACs). In cancer …

    duquesne Repository record for DESIGN AND SYNTHESIS OF FUSED PYRIMIDINES AS SINGLE AGENTS WITH COMBINATION CHEMOTHERAPY POTENTIAL, AS TUBULIN POLYMERIZATION AND ONE-CARBON METABOLISM INHIBITORS FOR CANCER (opens in a new tab)

  3. Discovery of Pyrimidine-based Heterocycles as Single Agents With Combination Chemotherapy Potential And As Inhibitors Of Purine Nucleotide Biosynthesis For The Treatment of Cancer

    … and bicyclic pyrimidine-base heterocycles as single agents with combination chemotherapy potential having both antiangiogenic effects and cytotoxic effects. This dissertation also describes selective tumor targeting with 5-substituted pyrrolo[2,3-<em>d</em>]pyrimidines analogs with heteroatom …

    duquesne Repository record for Discovery of Pyrimidine-based Heterocycles as Single Agents With Combination Chemotherapy Potential And As Inhibitors Of Purine Nucleotide Biosynthesis For The Treatment of Cancer (opens in a new tab)

  4. Design and synthesis of pyrimido[4,5-b]indoles and furo[2,3-d]pyrimidines as single agents with combination chemotherapy potential or as inhibitors of tubulin or thymidylate synthase

    … research progress in the areas of multitargeted single agents and tubulin inhibitors in cancer chemotherapy and selective Toxoplasma gondii TS inhibitors for the treatment of toxoplasmosis. Tubulin inhibitors are important antitumor agents that disrupt microtubule dynamics. Thymidylate synthase …

    duquesne Repository record for Design and synthesis of pyrimido[4,5-b]indoles and furo[2,3-d]pyrimidines as single agents with combination chemotherapy potential or as inhibitors of tubulin or thymidylate synthase (opens in a new tab)

  5. Preclinical Evaluation of Oral Metronomic Topotecan and Pazopanib for the Treatment of Aggressive Extracranial Pediatric Solid Tumors

    … lines. In-vivo antitumor efficacies of drugs, as single agents and combination, were tested in immunodeficient mice models. For studying the mechanisms of resistance to our therapy, a time-response study (28, 56 and 80 days) was conducted in SK-N-BE(2) xenografts model, treated in same way as …

    toronto-retro Repository record for Preclinical Evaluation of Oral Metronomic Topotecan and Pazopanib for the Treatment of Aggressive Extracranial Pediatric Solid Tumors (opens in a new tab)

  6. Epigenetic Therapy as a Primer for Immunotherapy

    DNA hypomethylating agents (HMAs) are at the forefront of epigenetic modulators for cancer treatments. As single agents, their efficacy is mainly appreciated in hematological studies prompting the development of second-generation DNA methylation inhibitors and drug delivery avenues. One of the …

    toronto-retro Repository record for Epigenetic Therapy as a Primer for Immunotherapy (opens in a new tab)

  7. Investigating the Blockade of Transforming Growth Factor-beta Signaling in Preclinical Models of Epithelial Ovarian Cancer

    … toxicity, or insufficient efficacy as single agents. In EOC, TGF-β signaling networks induce epithelial-mesenchymal transition (EMT)-mediated metastasis and promote resistance to platinum chemotherapy. In this thesis, novel synthetic antibody fragments targeting TGF-β receptor II …

    queens Repository record for Investigating the Blockade of Transforming Growth Factor-beta Signaling in Preclinical Models of Epithelial Ovarian Cancer (opens in a new tab)

  8. Synergistic impact of co-targeting tropomyosin 3.1 and microtubules in ovarian cancer cells

    Anti-microtubule agents are widely used to treat ovarian cancers in the first line and recurrent setting either in combination with platinum or as single agents. This work investigates co-targeting the actin cytoskeleton in combination with anti-microtubule agents to increase efficacy of treatment …

    unsw Repository record for Synergistic impact of co-targeting tropomyosin 3.1 and microtubules in ovarian cancer cells (opens in a new tab)

  9. CHEMICAL-CHEMICAL COMBINATIONS AS TOOLS OF BIOLOGY AND AS ROUTES TO DRUG DISCOVERY

    … has been centered almost entirely on identifying single agents that target essential proteins or enzymes. Recent advances in systems biology have suggested that this paradigm may not be as therapeutically effective as combinations of drugs. Further, chemical-chemical combinations, rather than …

    mcmaster Repository record for CHEMICAL-CHEMICAL COMBINATIONS AS TOOLS OF BIOLOGY AND AS ROUTES TO DRUG DISCOVERY (opens in a new tab)

  10. Rh2 and its aglycone aPPD in combination therapy with docetaxel - pre-clinical evaluation in a PC-3 human prostate

    … biodistribution and efficacy of Rh2 and aPPD as single agents, and (ii) the combination of Rh2 or aPPD with docetaxel with the goal of optimizing their therapeutic potential. METHODS: The solubility and stability of Rh2 and aPPD in ethanol was determined and an oral dosage formulation was …

    ubc Repository record for Rh2 and its aglycone aPPD in combination therapy with docetaxel - pre-clinical evaluation in a PC-3 human prostate (opens in a new tab) Download PDF for Rh2 and its aglycone aPPD in combination therapy with docetaxel - pre-clinical evaluation in a PC-3 human prostate (opens in a new tab)

  11. The effect of potential anticancer gene products on breast cancer cell lines

    … therapeutics typically has been investigated as single agents. More recently combinatorial agents have been investigated for which some combinations have shown synergism. The present study was designed to evaluate three different potential anticancer factors, decorin, interferon beta (IFNb), and …

    umn Repository record for The effect of potential anticancer gene products on breast cancer cell lines (opens in a new tab)

  12. The effect of bromalin and N-Acetylcysteine (NAC) on chemotherapeutic drug uptake by cancer cells in relation to their mucin and human nucleoside transporter profiles

    … effects of bromelain, NAC, and gemcitabine as single agents or in combination against a panel of pancreatic cancer cell lines in vitro. I observed that bromelain and NAC exert cytotoxic effect as single agents, though combination treatments significantly increase potency. The addition of …

    unsw Repository record for The effect of bromalin and N-Acetylcysteine (NAC) on chemotherapeutic drug uptake by cancer cells in relation to their mucin and human nucleoside transporter profiles (opens in a new tab)

  13. THERAPEUTIC EFFICACY OF COMBINATION OF MTOR INHIBITORS AND AMPK ACTIVATORS IN NON-SMALL CELL LUNG CANCER.

    … of mTORC1 substrates S6K1 and 4E-BP1, as single agents and in combination, at their 50% inhibitory concentrations (IC50) by western blotting. Our data suggested that AMPK activation via PTX mediated AICART inhibition in combination with direct mTOR inhibition by AZD8055 has a synergistic …

    vcu Repository record for THERAPEUTIC EFFICACY OF COMBINATION OF MTOR INHIBITORS AND AMPK ACTIVATORS IN NON-SMALL CELL LUNG CANCER. (opens in a new tab)

  14. Design and Synthesis of Pyrimidine Based Heterocycles as Potential Anti-cancer Agents with Combination Chemotherapeutic Potential or Targeted One Carbon Metabolism Inhibition and Anti-opportunistic Agents

    … tricyclic pyrimidine-based heterocycles as a) single agents with combination chemotherapy potential having dual antiangiogenic effects and cytotoxic effects or b) one-carbon metabolism inhibitors for targeted tumor therapy; or c) selective Pneumocystis jirovecii (pj) dihydrofolate reductase …

    duquesne Repository record for Design and Synthesis of Pyrimidine Based Heterocycles as Potential Anti-cancer Agents with Combination Chemotherapeutic Potential or Targeted One Carbon Metabolism Inhibition and Anti-opportunistic Agents (opens in a new tab)

  15. PROOF OF CONCEPT FOR PAIR BASED APPROACH FOR SWARM ROBOTICS

    Many cases exist where teams of agents in a multi-agent system perform better than individual agents acting alone. In swarm robots, a large number of low-cost robots with limited functionality interact with each other and the environment to result in a more complex emergent behavior capable of …

    maryland Repository record for PROOF OF CONCEPT FOR PAIR BASED APPROACH FOR SWARM ROBOTICS (opens in a new tab)

  16. Novel Combination Therapy: Monensin Potentiates Erlotinib-Induced Cytotoxicity

    … however, they lack significant efficacy as single agents. As a result, RTK inhibitors require a combination based therapeutic approach with other treatment modalities. To uncover such a combination of agents, we performed a high throughput Prestwick library screen that included 1200 …

    ottawa-retro Repository record for Novel Combination Therapy: Monensin Potentiates Erlotinib-Induced Cytotoxicity (opens in a new tab)

  17. Supramolecular self-associating amphiphiles (SSAs) as novel enhancers of cancer treatment

    … SSAs and their potential as novel anticancer agents and adjuvants to existing chemotherapeutics in ovarian cancer, with a focus on overcoming drug resistance. This thesis also explores the activity of a panel of SSAs in bladder cancer to understand their potential to improve mitomycin C …

    kent Download PDF for Supramolecular self-associating amphiphiles (SSAs) as novel enhancers of cancer treatment (opens in a new tab)

  18. ΠΡΟΛΕΜΦΟΚΥΤΤΑΡΟΕΙΔΗΣ ΜΕΤΑΤΡΟΠΗ ΕΠΙ ΧΡΟΝΙΑΣ ΛΕΜΦΟΓΕΝΟΥΣ ΛΕΥΧΑΙΜΙΑΣ ΚΑΙ Η ΠΡΟΓΝΩΣΤΙΚΗ ΑΞΙΑ ΑΥΤΗΣ

    … 5 BECAMEREFRACTORY TO ANY GIVEN TREATMENT (SINGLE AGENTS, COMBINATION CHEMOTHERAPY, SPLEEN IRRADIATION). AMONG THEM 3 DEVELOPED PERSISTENT HAEMOLYTIC ANAEMIA ANDALL DIED OF INFECTION, THROMBOCYTOPENIA AND ANAEMIA IN A PERIOD RANGED FROM 1 - 2,5 YEARS. THE TEST 2 PATIENTS HAD VERY SHORT …

    greece Repository record for ΠΡΟΛΕΜΦΟΚΥΤΤΑΡΟΕΙΔΗΣ ΜΕΤΑΤΡΟΠΗ ΕΠΙ ΧΡΟΝΙΑΣ ΛΕΜΦΟΓΕΝΟΥΣ ΛΕΥΧΑΙΜΙΑΣ ΚΑΙ Η ΠΡΟΓΝΩΣΤΙΚΗ ΑΞΙΑ ΑΥΤΗΣ (opens in a new tab)

  19. Target Based Design And Synthesis of Heterocycles in the Potential Treatment of Cancer and Opportunistic Infection

    … cancer chemotherapy. Microtubule targeting agents (MTAs) are a structurally diverse set of compounds that disrupt microtubule dynamics and exert their anticancer effect. Among the various classes of such agents, the colchicine site binding agents are particularly important as they circumvent …

    duquesne Repository record for Target Based Design And Synthesis of Heterocycles in the Potential Treatment of Cancer and Opportunistic Infection (opens in a new tab)

  20. Therapeutic Targeting of Polo-like Kinase 1 in Diffuse Midline Glioma

    … inhibitors in patient-derived DMG cell lines. As single agents these inhibitors produced potent anti-tumour activity in vitro, characterised by G2/M checkpoint arrest, accumulation of unrepaired DNA damage and induction of apoptosis. When combined with ionising radiation the inhibitors produced …

    unsw Repository record for Therapeutic Targeting of Polo-like Kinase 1 in Diffuse Midline Glioma (opens in a new tab) Embargoed

Page 1 of 6